[PRLD] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[PRLD] Prelude Therapeutics Incorporated
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -15.61%
YoY- -20.34%
Quarter Report
PRLD's Result
PRLD's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 0 3,424 0 0 0 0 0 -
PBT -31,431 -33,075 -30,608 -30,431 -27,718 -28,641 -29,958 3.24%
Tax -426 1,676 -279 239 -1,397 -7,654 -448 -3.29%
NP -31,431 -33,075 -30,608 -30,431 -26,321 -20,987 -29,510 4.28%
Tax Rate - - - - - - - -
Total Cost 31,431 36,499 30,608 30,431 26,321 20,987 29,510 4.28%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.00 -965.98 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.42 -0.48 -0.45 -0.54 -0.55 -0.44 -0.62 -22.84%
EPS Diluted -0.42 -0.48 -0.45 -0.54 -0.55 -0.44 -0.62 -22.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.